MARK RYAN: Open Payments
NPI 1568020626 · NORTHAMPTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 29 payments from 17 companies in 2025. Trend: 2023 $281 · 2024 $563 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $102 |
| Exact Sciences Corporation | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| Indivior Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
Products named: UBRELVY, SUBLOCADE, Auvelity, AIRSUPRA, VOWST, Veozah, VIVITROL, CAMZYOS.
Industry payments across MA — which companies pay providers there.
